Thomas N. Sato, Ph.D.
Scientific Founder and Chair of Board of Directors, Karydo TherapeutiX, Inc.
Research Director, ERATO Sato Live Bio-forecasting Project, Japanese Science and Technology Agency, Kyoto, Japan
Adjunct Professor, Cornell University, Graduate School of Biomedical Engineering, New York, USA
Affiliate Member, Centenary Institute, Sydney, Australia
Awards and Honors:
|1973||1st place winner of National Science Contest for Elementary School Students (Japan)|
|1983||American Heart Association, Established Investigator Award（-2001）|
|1985||Predoctoral Fellowship, Georgetown University, Washington, DC (-1988)|
|1987||Cold Spring Harbor Summer Fellowship, Cold Spring Harbor Laboratories, Cold Spring Harbor, NY|
|1998||American Heart Association, Established Investigator Award (-2001)|
|2005||Jokichi Takamine Research Award (Japanese Endocrinology and Cardiovascular Society)|
|2006||Listed among the top 1% most cited authors for journals in Molecular Biology and Genetics|
|2006||Scientific Advisory Board Member, Surface Logix, Inc. (-2008)|
Accomplishment in Technology Development:
UTSD:0672 (UT Southwestern Medical Center at Dallas, Texas, USA) "Transgenic Mouse Expressing Green Fluorescent Protein Specifically In Vascular Endothelium (Tie2-GFP Mouse) (JAX strain 003658)"
Genentech, Inc., Novartis Institutes for Biomedical Research, Sanofi-Synthelabo Recherche, Bayer AG, Columbia Innovation Enterprise, ImClone Systems Incorporated, Jackson Laboratory, Monsanto Company, Merck & Co., Inc.
Other notable accomplishments:
Dr. Sato is an Ironman Triathlete and completed several Ironman triathlon races including Ironman Lake Placid, Ironman Japan, Ironman Coeur d’Alene.